Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma

Khlooud Sayed
2017 Sohag Medical Journal  
Purpose To study the value of adding collagen matrix (CM) to the surgical procedure combined trabeculotomy-trabeculectomy with mitomycin C (CTTM) for the treatment of Primary congenital glaucoma (PCG). Patients and methods Fourty eyes were operated upon. The CM was inserted under the scleral and conjunctival flaps. Follow up was for 6 -12months Results At 6 months; all eyes manifested full success. At 1 year; one eye manifested poor success. There were minimal complications in the form of
more » ... perative hyphema, vitreous loss and postoperative shallow anterior chamber, immunological reaction and thin avascular cystic blebs. Conclusion This study is novel in using both MMC and CM implant at the same time for augmentation of CTT procedure with highest success ever reported for PCG. Biodegradable CM markedly increased the short and long term surgical success with marked reduction of complications.
doi:10.21608/smj.2017.41239 fatcat:y2mjk4fj45d7no7zdjbc6mxqrm